We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 866

The “gene patent” dichotomy between the US and Australia
  • Shelston IP Pty Ltd
  • USA, Australia
  • March 6 2018

The recent Meat & Livestock Australia Limited v Cargill, Inc (MLA) Federal Court decision has brought the significant differences that exist between


EU Court Offers Preview of Potential Regulatory Approach for Gene Edited Plants
  • Arent Fox LLP
  • USA, European Union
  • February 15 2018

Late last month, an advisor to the Court of Justice of the European Union issued an opinion recommending that plants produced using innovative


Gene Therapy: Pipeline of Possibilities but Challenges for Pricing
  • Manatt Phelps & Phillips LLP
  • USA
  • January 25 2018

One of the therapeutic areas in development that represents the greatest scientific promise is gene therapy. Gene therapy's potential is


Genetic code meets Canada Labour Code
  • McCarthy Tétrault LLP
  • USA, Canada
  • October 5 2017

Genes are the building blocks of life, shaping our physical traits, personal characteristics, and our biological make-up, and the field of genetic


Witwenrente auch für die zweite Ehefrau?
  • Beiten Burkhardt
  • Germany
  • July 3 2017

Der (frühere) Arbeitnehmer nimmt den Pensionssicherungsverein als gesetzlichen Insolvenzsicherungsträger auf Feststellung in Anspruch, dass seiner


2016-2017 Technical Review of Gene Technology Regulations 2001
  • K&L Gates
  • Australia
  • January 10 2017

The deadline for submissions on the Discussion Paper prepared by the Office of the Australian Gene Technology Regulator (OGTR) concerning its review


Balancing Gene Therapy’s Promise and Price
  • Manatt Phelps & Phillips LLP
  • USA
  • December 19 2016

Gene therapy is the therapeutic delivery of polymers into a patient’s cells for the purpose of treating a disease. Polymers interfere with gene


Review of Australia’s Gene Technology Regulations: An Opportunity to Strengthen Australia’s Biotechnology Industry
  • K&L Gates
  • Australia
  • November 23 2016

As Australia faces the challenges that come with the end of the resources boom and a shift away from many traditional manufacturing industries, the


Breveter le vivant : une question qui gène
  • Blake Cassels & Graydon LLP
  • Canada
  • October 27 2016

Si la Cour suprême du Canada (CSC) a déjà commenté l’épineuse question de savoir si les gènes peuvent être brevetés, aucun tribunal canadien n’a


Patenting in Canada: Do These Genes Fit?
  • Blake Cassels & Graydon LLP
  • USA, Australia, Canada
  • October 27 2016

The Supreme Court of Canada has commented on the issue but no Canadian court has directly answered the difficult question of whether genes are